相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation
Max Liebregts et al.
EUROPACE (2018)
Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals
Farbod Sedaghat-Hamedani et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy
Jan Haas et al.
EMBO MOLECULAR MEDICINE (2018)
Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals
Elham Kayvanpour et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy
Stefania Rosmini et al.
HEART (2017)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A. Hughes et al.
JOURNAL OF MEDICAL GENETICS (2017)
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy
Farbod Sedaghat-Hamedani et al.
EUROPEAN HEART JOURNAL (2017)
Correction of a pathogenic gene mutation in human embryos
Hong Ma et al.
NATURE (2017)
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
Maksymilian Prondzynski et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing
Concetta Schiano et al.
CARDIOLOGY JOURNAL (2017)
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure
Benjamin Meder et al.
CIRCULATION (2017)
Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy
Marla B. Sultan et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2017)
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy The Past, Present, and Future
Brian P. Halliday et al.
CIRCULATION (2017)
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
Brian P. Halliday et al.
CIRCULATION (2017)
Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction
Robert Hastings et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers
Saurabh Kumar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells
Florian Weinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
An 'Omics' Perspective on Cardiomyopathies and Heart Failure
Rajendra Raghow
TRENDS IN MOLECULAR MEDICINE (2016)
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy
Carolina M. Greco et al.
NATURE COMMUNICATIONS (2016)
The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the Art
Stefano de Franciscis et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction
Robert Hastings et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Personalized Computer Simulation of Diastolic Function in Heart Failure
Ali Amr et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
Microvolt T-wave Alternans: Where Are We Now?
Aapo L. Aro et al.
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW (2016)
Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
Youfang Chen et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure
Sandra C. Mayer et al.
CIRCULATION RESEARCH (2015)
Biomarker Changes after Strenuous Exercise Can Mimic Pulmonary Embolism and Cardiac Injury-A Metaanalysis of 45 Studies
Farbod Sedaghat-Hamedani et al.
CLINICAL CHEMISTRY (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Towards Personalized Cardiology: Multi-Scale Modeling of the Failing Heart
Elham Kayvanpour et al.
PLOS ONE (2015)
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy
Ioannis Karakikes et al.
NATURE COMMUNICATIONS (2015)
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers A Pilot Randomized Trial to Modify Disease Expression
Carolyn Y. Ho et al.
JACC-HEART FAILURE (2015)
Atlas of the clinical genetics of human dilated cardiomyopathy
Jan Haas et al.
EUROPEAN HEART JOURNAL (2015)
Genetic Diagnosis of cardiovascular Disease Position Paper of the German Society of Cardiology (DGK) and German Society of Pediatric Cardiology (DGPK)
E. Schulze-Bahr et al.
KARDIOLOGE (2015)
Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats
DaLiao Xiao et al.
CARDIOVASCULAR RESEARCH (2014)
Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure
Regalla Kumarswamy et al.
CIRCULATION RESEARCH (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis
Saskia M. Rombach et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Wytyczne ESC dotyczące rozpoznawania i postępowania w kardiomiopatii przerostowej w 2014 roku
Perry M. Elliott et al.
Kardiologia Polska (2014)
Inhibition of miR-25 improves cardiac contractility in the failing heart
Christine Wahlquist et al.
NATURE (2014)
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice
Giulia Mearini et al.
NATURE COMMUNICATIONS (2014)
Alterations in cardiac DNA methylation in human dilated cardiomyopathy
Jan Haas et al.
EMBO MOLECULAR MEDICINE (2013)
Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure
Britta Vogel et al.
EUROPEAN HEART JOURNAL (2013)
Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
Ankur Gulati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile Dysfunction
Priyatansh Gurha et al.
CIRCULATION (2012)
RNAi-based Gene Therapy for Dominant Limb Girdle Muscular Dystrophies
Jian Liu et al.
CURRENT GENE THERAPY (2012)
Abnormal p38 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation
Antoine Muchir et al.
HUMAN MOLECULAR GENETICS (2012)
Genetics of Hypertrophic Cardiomyopathy After 20 Years Clinical Perspectives
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers A European Cohort Study
Ingrid A. W. van Rijsingen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Truncations of Titin Causing Dilated Cardiomyopathy
Daniel S. Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mitogen-Activated Protein Kinase Inhibitor Regulation of Heart Function and Fibrosis in Cardiomyopathy Caused by Lamin A/C Gene Mutation
Antoine Muchir et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2012)
Distinct Epigenomic Features in End-Stage Failing Human Hearts
Mehregan Movassagh et al.
CIRCULATION (2011)
S100A1 gene therapy for heart failure: A novel strategy on the verge of clinical trials
David Rohde et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Pervasive roles of microRNAs in cardiovascular biology
Eric M. Small et al.
NATURE (2011)
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
Stephen Connelly et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
Chromatin regulation by Brg1 underlies heart muscle development and disease
Calvin T. Hang et al.
NATURE (2010)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)